Machine Learning Models for the Noninvasive Diagnosis of Bladder Outlet Obstruction and Detrusor Underactivity in Men With Lower Urinary Tract Symptoms
International Neurourology Journal · 30.11.2024 · 28 (Suppl 2) · S74-81
DOI: 10.5213/inj.2448360.180 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Neurourology Journal, erschienen am 30.11.2024. Verfasst von Hyungkyung Shin und 5 weiteren Autor:innen. Beteiligte Einrichtung: Acryl Advanced AI Research Center, Acryl Inc., Seoul, Korea. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 16 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0). Gefördert von: National IT Industry Promotion Agency, Ministry of Science and ICT.
Abstract (Originalsprache)
Purpose
This study aimed to develop and evaluate machine learning models, specifically CatBoost and extreme gradient boosting (XGBoost), for diagnosing lower urinary tract symptoms (LUTS) in male patients. The objective is to differentiate between bladder outlet obstruction (BOO) and detrusor underactivity (DUA) using a comprehensive dataset that includes patient-reported outcomes, uroflowmetry measurements, and ultrasound-derived features.
Methods
The dataset used in this study was collected from male patients aged 40 and older who presented with LUTS and sought treatment at the urology department of Samsung Medical Center. We developed and trained CatBoost and XGBoost models using this dataset. These models incorporated features like prostate size, voiding parameters, and responses from questionnaires. Their performance was assessed using standard metrics such as accuracy, precision, recall, F1-score, and area under the receiver operating characteristic curve (AUROC).
Results
The results indicated that the CatBoost models displayed greater sensitivity, rendering them effective for initial screenings by accurately identifying true positive cases. Conversely, the XGBoost models showed higher specificity and precision, making them more suitable for confirming diagnoses and reducing false positives. In terms of overall performance for both BOO and DUA, XGBoost surpassed CatBoost, achieving an AUROC of 0.826 and 0.819, respectively.
Conclusions
Integrating these machine learning models into the diagnostic workflow for LUTS can significantly enhance clinical decision-making by offering noninvasive, cost-effective, and patient-friendly diagnostic alternatives. The combined application of CatBoost and XGBoost models has the potential to improve diagnostic accuracy and provide customized treatment plans for patients, ultimately leading to better clinical outcomes.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Acryl Advanced AI Research Center, Acryl Inc., Seoul, Korea.
- Department of Urology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
- College of Computing and Informatics, Sungkyunkwan University, Suwon, Korea.
Förderung
- National IT Industry Promotion Agency
- Ministry of Science and ICT
Zitieren
APA
Shin, H., Ko, K. J., Park, W. J., Han, D. H., Yeom, I., & Lee, K. S. (2024). Machine Learning Models for the Noninvasive Diagnosis of Bladder Outlet Obstruction and Detrusor Underactivity in Men With Lower Urinary Tract Symptoms. International Neurourology Journal, 28(Suppl 2), S74-81. https://doi.org/10.5213/inj.2448360.180
Vancouver
Shin H, Ko KJ, Park WJ, Han DH, Yeom I, Lee KS. Machine Learning Models for the Noninvasive Diagnosis of Bladder Outlet Obstruction and Detrusor Underactivity in Men With Lower Urinary Tract Symptoms. International Neurourology Journal. 2024;28(Suppl 2):S74-81. doi:10.5213/inj.2448360.180
BibTeX
@article{Shin2024,
author = {Shin, Hyungkyung and Ko, Kwang Jin and Park, Wei-Jin and Han, Deok Hyun and Yeom, Ikjun and Lee, Kyu-Sung},
title = {Machine Learning Models for the Noninvasive Diagnosis of Bladder Outlet Obstruction and Detrusor Underactivity in Men With Lower Urinary Tract Symptoms},
journal = {International Neurourology Journal},
year = {2024},
volume = {28},
number = {Suppl 2},
pages = {S74--81},
doi = {10.5213/inj.2448360.180}
}
EUVIMED